<DOC>
	<DOCNO>NCT02077218</DOCNO>
	<brief_summary>This pilot clinical trial study compute tomography ( CT ) scan biomarker analysis diagnose coronary artery disease ( CAD ) patient undergone stem cell transplant symptom CAD . CAD disease narrow blockage coronary artery ( blood vessel carry blood oxygen heart ) patient undergone stem cell transplant especially high risk CAD . A CT scan involves series detail picture area inside body take different angle . The picture create computer link x-ray machine . Studying sample blood patient undergone stem cell transplant laboratory may help doctor identify learn biomarkers related CAD . Using CT scan combination biomarker analysis may better less-invasive way diagnose CAD .</brief_summary>
	<brief_title>Computed Tomography Biomarker Analysis Diagnosing Coronary Artery Disease Asymptomatic Patients Who Have Undergone Stem Cell Transplant</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Evaluate feasibility use CT-based imaging blood biomarkers assessment asymptomatic coronary artery disease ( CAD ) survivor allogeneic hematopoietic stem cell transplant ( HCT ) . SECONDARY OBJECTIVES : I . Determine prevalence severity asymptomatic CAD , measure CT angiography . II . Describe association patient demographic ( age , sex , race/ethnicity ) , pre-HCT chest radiation , HCT-related exposure ( total body irradiation [ TBI ] , condition chemotherapy ) , graft-versus-host disease ( GvHD ) management cardiovascular risk factor ( CVRFs ) extent CAD . III . Describe association asymptomatic CAD candidate blood biomarkers vessel injury inflammation ( high-sensitivity C-reactive protein [ hs-CRP ] , lipoprotein-associated phospholipase A2 [ Lp-PLA2 ] ) . OUTLINE : Patients undergo cardiac CT collection blood sample analysis hs-CRP via quantitative immunoturbidimetry Lp-PLA2 via enzyme-linked immunosorbent assay ( ELISA ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Alive complete remission time enrollment Underwent allogeneic HCT 1995 Time HCT study entry : &gt; = 2 year Have least one CVRF ( hypertension , diabetes , dyslipidemia ) time eligibility determination History ischemic heart disease , stroke , cardiomyopathy/congestive heart failure Abnormal renal function ( glomerular filtration rate [ GFR ] &lt; 60 mL/min/1.73m2 ) Pregnancy Known allergy intravenous ( IV ) contrast Sustained symptomatic ventricular dysrhythmias uncontrolled drug therapy implantable device ; significant conduction defect ( i.e . : second third degree atrioventricular block sick sinus syndrome ) Current clinical evidence moderatetosevere obstructive pulmonary disease reactive airway disease ( i.e . : asthma ) require therapy History drug sensitivity allergic reaction betablockers Currently take calcium channel blocker verapramil diltiazem History unrepaired severe aortic stenosis</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>